Latest S-1 registration statements

Rapport Therapeutics, a clinical-stage biopharmaceutical company, has filed for an initial public offering to fund the development of its small molecule medicines for central nervous system disorders.

Edible Garden AG plans to raise up to $15 million through a public offering of units, each including common stock or a pre-funded warrant, and Class A and Class B warrants.

QT Imaging Holdings aims to raise capital and provide liquidity for selling securityholders through the registration of up to 43,795,000 shares of common stock and 889,364 warrants.

Banzai International, Inc. enters into a securities purchase agreement to issue and sell shares of Class A common stock and warrants to identified purchasers.

Dynamic Shares Trust files a pre-effective amendment to its Form S-1 registration statement for the Dynamic Short Short-Term Volatility Futures ETF, aiming for public sale commencement.

AgEagle Aerial Systems is registering 5.47 million shares of common stock for resale by selling shareholders following recent private placement transactions.

Waystar Holding Corp. is going public to raise capital for debt repayment and general corporate purposes, seeking to streamline healthcare payments through its cloud-based software.

Benitec Biopharma is registering for resale 32,871,201 shares of common stock to satisfy registration rights granted in connection with a recent $40 million private placement.

NioCorp Developments Ltd. has filed an S-1 registration statement for the potential resale of up to 4,834,066 common shares by existing selling shareholders.

FibroBiologics is launching a best-efforts offering of up to 1,801,801 units, each comprising a share of common stock and a warrant, to raise capital for research, development, and general corporate purposes.

Sonnet BioTherapeutics is seeking to raise up to $25 million through a committed equity facility with Chardan Capital Markets, potentially diluting existing shareholders.

Applied DNA Sciences aims to raise capital to further develop its Therapeutic DNA Production and MDx Testing Services through a public offering of common stock, warrants, and pre-funded warrants.

Lionsgate Studios Corp. files an amendment for the resale of up to 26.2 million common shares by selling shareholders following a business combination.

Cardiff Lexington Corporation files an amended registration statement for a proposed offering of 1,600,000 shares of common stock, contingent upon uplisting to NYSE American or Nasdaq.

Kaival Brands Innovations Group, Inc. is launching a best efforts offering of units and pre-funded units to raise up to $5 million, as detailed in its S-1/A filing, while navigating a complex regulatory landscape for ENDS products.

Korro Bio is registering the resale of up to 1,213,569 shares of its common stock by selling stockholders, with the company not receiving any proceeds from the sale.

AgEagle Aerial Systems files an amendment to its S-1 registration statement, covering the resale of up to 5,470,760 shares of common stock by selling shareholders.

Lakeside Holding Limited has filed Amendment No. 2 to its Form S-1 registration statement with the SEC, pertaining to its initial public offering of common stock.

LGAC International LLC and Lions Gate Capital Holdings 1, Inc. enter into a bi-directional revolving credit facility agreement with a borrowing limit of $150 million.

AtlasClear Holdings has filed a registration statement for the potential resale of up to 37,885,852 shares of its common stock by selling stockholders.

Aditxt, Inc. files an amendment to its S-1 registration statement, detailing the potential resale of 3,785,569 shares of common stock by a selling stockholder and the possibility of generating $12.3 million through warrant exercises.

Scorpius Holdings has filed a registration statement to register $1.38 million in shares of common stock issuable upon the exercise of warrants.

Cheetah Net Supply Chain Service Inc. is registering an additional 3,210,000 shares of Class A common stock via Form S-1MEF, supplementing a previous registration to increase the aggregate offering.

Jet.AI Inc. has filed a registration statement for the resale of up to 12.2 million shares of its common stock by a selling stockholder.

Virpax Pharmaceuticals is launching a best efforts offering of common stock and warrants, aiming to raise approximately $4.4 million for working capital and general corporate purposes.

Aethlon Medical launches a best-efforts offering of common stock and warrants to fund research, clinical trials, and general corporate activities.

Heritage Distilling Holding Company seeks to go public, offering 2,000,000 shares of common stock with an estimated price range of $4.50 to $5.50 per share.

Energy and Water Development Corp. files an amendment to its registration statement for a public offering and resale of common stock, aiming for a NYSE American listing.

NKGen Biotech aims to raise capital through the potential exercise of outstanding warrants while registering the resale of a significant number of common shares by existing securityholders.

HNR Acquisition Corp files an amendment to its registration statement for the resale of up to 18.4 million shares of Class A Common Stock by selling securityholders following its business combination with Pogo Resources.